Zhuhai Trinomab Pharmaceutical Co., Ltd.

This study tested whether a new antibody injection called TNM001 could prevent serious lung infections caused by Respiratory Syncytial Virus (RSV) in high-risk infants. About 315 infants under 1 year old entering their first RSV season received either the antibody or a placebo sh…

This study tested whether an injection called TNM001 could safely prevent serious lower respiratory tract infections caused by RSV in infants under one year old. Over 2,200 babies, including some born prematurely or with certain heart or lung conditions, received either the injec…

This study tested a new antibody injection called TNM002 to see if it could protect against tetanus as well as or better than the current standard treatment. Researchers gave a single shot to 240 healthy Chinese adults and compared how long and how strongly their bodies produced …